Yersinia pestis F1 protein, also known as Fraction 1 antigen, plays a pivotal role in the pathogenesis of Yersinia pestis, the causative agent of plague. This protein is a major component of the bacterial capsule, contributing to the organism's virulence and its ability to evade host immune responses. The F1 antigen forms a protective layer around the bacterial cell surface, inhibiting phagocytosis by host immune cells and facilitating the establishment of infection. Additionally, it contributes to biofilm formation, promoting bacterial persistence and dissemination within the host organism. Through its interactions with host cells and immune evasion mechanisms, Y. pestis F1 protein facilitates the progression of plague infection and contributes to the severity of disease manifestations.
Activation of Yersinia pestis F1 protein involves complex molecular mechanisms that facilitate its expression, assembly, and functional activity. One key aspect of activation is the upregulation of F1 gene expression in response to environmental cues encountered by the bacterium during infection. This process may involve signaling pathways that sense host-derived signals, such as temperature shifts and nutrient availability, triggering the induction of F1 antigen production. Additionally, post-translational modifications and chaperone-mediated protein folding pathways may contribute to the proper assembly and stability of F1 protein complexes on the bacterial cell surface. Activation of Y. pestis F1 protein is essential for the bacterium to establish infection and evade host immune responses, highlighting its importance as a virulence factor in the pathogenesis of plague.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS from E. coli can stimulate the immune system via toll-like receptor 4 (TLR4), leading to a cascade that results in the activation of antigen-presenting cells. These cells could then more effectively present Yersinia pestis F1 antigen to T cells. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly I:C is a synthetic analog of double-stranded RNA that activates TLR3. Activation of this pathway can enhance the immune response to antigens like Yersinia pestis F1 by promoting the secretion of type I interferons. | ||||||
Aluminum hydroxide | 21645-51-2 | sc-214529 sc-214529A | 100 g 500 g | $39.00 $55.00 | 3 | |
Imiquimod is a TLR7 agonist that can induce the production of proinflammatory cytokines, enhancing the innate immune response and thus potentially increasing the recognition of Yersinia pestis F1 by the immune system. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R-848 is a TLR7 and TLR8 agonist that can stimulate innate immune responses, potentially improving the adaptive immune response to the Yersinia pestis F1 antigen. | ||||||
GM-CSF | 83869-56-1 | sc-280759 | 5 µg | $516.00 | 1 | |
GM-CSF is a cytokine that can enhance the maturation and function of dendritic cells, leading to improved antigen presentation and a stronger immune response to antigens such as Yersinia pestis F1. | ||||||